Dot Therapeutics-2 Inc (DAWN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
CEO:
Jeremy Bender
Employees:
60
395 OYSTER POINT BLVD STE 217, SOUTH SAN FRANCISCO, CA 94080-1930
206-913-4300

Day One Biopharmaceuticals, Inc. develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor.

Data derived from most recent annual or quarterly report
Market Cap 1.573 Billion Shares Outstanding73.461 Million Avg 30-day Volume 476.463 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.76 Million
Price to Revenue0.0 Debt to Equity0.0 EBITDA-125.72 Million
Price to Book Value3.9175 Operating Margin0.0 Enterprise Value1.048 Billion
Current Ratio20.826 EPS Growth0 Quick Ratio20.488
1 Yr BETA 0.3415 52-week High/Low 28.35 / 5.44 Profit Margin0.0
Operating Cash Flow Growth-112.3874 Altman Z-Score44.6359 Free Cash Flow to Firm 0
View SEC Filings from DAWN instead.

View recent insider trading info

Funds Holding DAWN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DAWN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

109.8 Thousand total shares from 17 transactions

Exercise Derivative Conversion (M)

6.1 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

YORK CHARLES N II COO, CFO AND SECRETARY

  • Officer
286,497 2022-11-21 11

BENDER JEREMY CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,768,072 2022-11-21 12

BLACKMAN SAMUEL C. CHIEF MEDICAL OFFICER

  • Officer
3,554,925 2022-11-15 11

GRANT JULIE PAPANEK

  • Director
419,358 2022-11-01 14

CANAAN XI L.P.

CANAAN PARTNERS XI LLC

  • 10% Owner
6,964,301 2022-09-21 5

ATLAS VENTURE FUND XI, L.P.

  • 10% Owner
6,609,388 2022-09-19 2

NICHOLSON GARRY A

  • Director
0 2022-09-12 2

ATLAS VENTURE OPPORTUNITY FUND I, L.P.

  • 10% Owner
793,116 2022-07-01 1

GARLAND J. SCOTT

  • Director
28,700 2022-06-21 1

RAMASASTRY SAIRA

  • Director
28,700 2022-06-21 1

HOLLES NATALIE C.

  • Director
28,700 2022-06-21 1

BECKER DANIEL J.

  • Director
28,700 2022-06-21 1

JOSEY JOHN A.

  • Director
28,700 2022-06-21 1

GLADSTONE MICHAEL

  • Director
28,700 2022-06-21 2

AI DAY1 LLC

ACCESS INDUSTRIES HOLDINGS LLC

ACCESS INDUSTRIES MANAGEMENT, LLC

BLAVATNIK LEN

  • 10% Owner
  • AFFILIATE OF 10% OWNERAFFILIATE OF 10% OWNERAFFILIATE OF 10% OWNER
10,684,638 2022-06-17 2

ATLAS VENTURE OPPORTUNITY FUND II, L.P.

ATLAS VENTURE FUND XI, L.P.

ATLAS VENTURE ASSOCIATES XI, L.P.

ATLAS VENTURE ASSOCIATES XI, LLC

ATLAS VENTURE OPPORTUNITY FUND I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

  • 10% Owner
8,984,019 2022-06-17 2

TAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICALS U.S.A., INC.

MILLENNIUM PHARMACEUTICALS INC

TAKEDA VENTURES, INC.

  • 10% Owner
6,120,124 2021-12-07 2

ATLAS VENTURE FUND XI, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

ATLAS VENTURE OPPORTUNITY FUND I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

ATLAS VENTURE ASSOCIATES XI, L.P.

ATLAS VENTURE ASSOCIATES XI, LLC

  • 10% Owner
500,000 2021-02-01 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

YORK CHARLES N II - Officer COO, CFO AND SECRETARY

2022-11-22 18:46:06 -0500 2022-11-21 S 300 $21.39 d 286,497 direct yes 1.2772 1.2772 2 0.0 1

YORK CHARLES N II - Officer COO, CFO AND SECRETARY

2022-11-22 18:46:06 -0500 2022-11-21 S 9,700 $20.74 d 286,797 direct yes 1.2772 1.2772 2 0.0 1

BENDER JEREMY - Director - Officer CHIEF EXECUTIVE OFFICER

2022-11-22 18:43:19 -0500 2022-11-21 S 400 $21.38 d 1,204,924 direct yes 1.2772 1.2772 2 0.0 1

BENDER JEREMY - Director - Officer CHIEF EXECUTIVE OFFICER

2022-11-22 18:43:19 -0500 2022-11-21 S 12,100 $20.74 d 1,205,324 direct yes 1.2772 1.2772 2 0.0 1

BENDER JEREMY - Director - Officer CHIEF EXECUTIVE OFFICER

2022-11-17 17:33:43 -0500 2022-11-16 S 1,513 $21.46 d 1,217,424 direct -4.358 0.0 1 -4.358 2

YORK CHARLES N II - Officer COO, CFO AND SECRETARY

2022-11-17 17:49:00 -0500 2022-11-16 S 430 $21.46 d 296,497 direct -4.358 0.0 1 -4.358 2

BLACKMAN SAMUEL C. - Officer CHIEF MEDICAL OFFICER

2022-11-17 17:41:39 -0500 2022-11-16 S 377 $21.46 d 1,270,148 direct -4.358 0.0 1 -4.358 2

BENDER JEREMY - Director - Officer CHIEF EXECUTIVE OFFICER

2022-11-17 17:33:43 -0500 2022-11-15 M 3,562 a 1,218,937 direct -4.358 0.0 1 -4.358 2

BENDER JEREMY - Director - Officer CHIEF EXECUTIVE OFFICER

2022-11-17 17:33:43 -0500 2022-11-15 M 3,562 d 42,752 direct

BLACKMAN SAMUEL C. - Officer CHIEF MEDICAL OFFICER

2022-11-17 17:41:39 -0500 2022-11-15 M 1,187 a 1,270,525 direct -4.358 0.0 1 -4.358 2

BLACKMAN SAMUEL C. - Officer CHIEF MEDICAL OFFICER

2022-11-17 17:41:39 -0500 2022-11-15 M 1,187 d 14,252 direct

YORK CHARLES N II - Officer COO, CFO AND SECRETARY

2022-11-17 17:49:00 -0500 2022-11-15 M 1,375 a 295,776 direct -4.358 0.0 1 -4.358 2

YORK CHARLES N II - Officer COO, CFO AND SECRETARY

2022-11-17 17:49:00 -0500 2022-11-15 M 1,375 d 16,500 direct

GRANT JULIE PAPANEK - Director see footnote

2022-11-03 17:44:23 -0400 2022-11-02 S 5,000 $20.01 d 419,358 indirect yes 1.1948 10.5974 10.5974 6 -2.4935 4

GRANT JULIE PAPANEK - Director see footnote

2022-11-03 17:44:23 -0400 2022-11-01 S 5,000 $20.04 d 424,358 indirect yes 1.1948 10.5974 10.5974 6 -2.4935 4

YORK CHARLES N II - Officer COO, CFO AND SECRETARY

2022-11-03 17:49:43 -0400 2022-11-01 S 10,000 $20.03 d 294,401 direct yes 1.1948 10.5974 10.5974 6 -2.4935 4

BENDER JEREMY - Director - Officer CHIEF EXECUTIVE OFFICER

2022-11-03 17:30:09 -0400 2022-11-01 S 12,500 $20.03 d 1,215,375 direct yes 1.1948 10.5974 10.5974 6 -2.4935 4

BLACKMAN SAMUEL C. - Officer CHIEF MEDICAL OFFICER

2022-11-03 17:36:29 -0400 2022-11-01 S 10,000 $20.01 d 1,269,338 direct yes 1.1948 10.5974 10.5974 6 -2.4935 4

GRANT JULIE PAPANEK - Director see footnote

2022-10-05 16:32:00 -0400 2022-10-04 S 5,000 $20.00 d 429,358 indirect yes -4.6806 0.195 2.8279 7.2647 28 -8.4837 25

BENDER JEREMY - Director - Officer CHIEF EXECUTIVE OFFICER

2022-10-05 16:22:03 -0400 2022-10-03 S 12,500 $20.05 d 1,227,875 direct yes -4.6806 0.195 2.8279 7.2647 28 -8.4837 25

YORK CHARLES N II - Officer COO, CFO AND SECRETARY

2022-10-05 16:36:13 -0400 2022-10-03 S 10,000 $20.05 d 304,401 direct yes -4.6806 0.195 2.8279 7.2647 28 -8.4837 25

GRANT JULIE PAPANEK - Director see footnote

2022-10-05 16:32:00 -0400 2022-10-03 S 5,000 $20.06 d 434,358 indirect yes -4.6806 0.195 2.8279 7.2647 28 -8.4837 25

BLACKMAN SAMUEL C. - Officer CHIEF MEDICAL OFFICER

2022-10-05 16:25:08 -0400 2022-10-03 S 10,000 $19.99 d 1,279,338 direct yes -4.6806 0.195 2.8279 7.2647 28 -8.4837 25

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 22:15:03 UTC 2.3624 1.4576 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 21:45:04 UTC 2.3624 1.4576 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 21:15:03 UTC 2.3624 1.4576 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 20:45:03 UTC 2.3624 1.4576 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 20:15:03 UTC 2.3624 1.4576 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 19:45:04 UTC 2.3624 1.4576 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 19:15:03 UTC 2.3624 1.4576 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 18:45:03 UTC 2.3624 1.4576 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 18:15:03 UTC 2.3624 1.4576 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 17:45:04 UTC 2.3528 1.4672 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 17:15:03 UTC 2.3528 1.4672 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 16:45:04 UTC 2.3528 1.4672 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 16:15:03 UTC 2.3528 1.4672 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 15:45:03 UTC 2.3528 1.4672 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 15:15:03 UTC 2.3528 1.4672 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 14:45:04 UTC 2.3528 1.4672 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 14:15:04 UTC 2.3528 1.4672 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 13:45:03 UTC 2.3528 1.4672 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 13:15:03 UTC 2.3528 1.4672 100000
DAY ONE BIOPHARMACEUTICALS I DAWN 2022-11-25 12:45:03 UTC 2.3528 1.4672 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund DAWN -346.0 shares, $-6930.38 2022-09-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund DAWN -400.0 shares, $-8012.0 2022-09-30 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments